Protocols

Preparation of pseudotyped lentiviral vectors resistant to complement inactivation

Summary

This experimental protocol describes several methods for generating complement-stabilized lentiviral vectors either by using fusion packaging proteins containing the complement regulatory protein CD55 (degradation acceleration factor, D A F ) to generate pseudotyped viral plasmids or by using naturally occurring D A F co-assembled with packaging proteins to generate novel lentiviruses.

Author: T. Friedman et al, Translated by W. Qin et al. This experiment is from "Gene Transfer".

Operation method

Preparation of lentiviral vectors

Move

Preparation of lentiviral vectors Materials

reagents

CaCl2 (2mol/L)

Dulbecco's modified Eagle's medium (DMEM) containing 4.5 g/L glucose (serum free complete) and 10 % fetal calf serum (FCS).

2 X HBS (HEPES-buffered saline)

50 mmol/L HEPES

280 mmol/L NaCl

I. 5 mmol/L Na2 HP 〇 4

Adjust pH to 7 .12 with 5 mol/L NaOH.

HEK 293 T Cells (ATCC, CRL 11268)

Phosphate buffer P B S

Plasmids

DAF encoded transgenic plasmid

Envelope-encoded plasmids (env)

Gp64-DAF fusion protein encoding transgenic plasmid

Packaging plasmids (pack)

Transgenic plasmids

VSV-ODAF fusion protein encoding transgenic plasmids

0.IX T E

10 mmol/L Tris-HCl ( p H 8.0)

lmmol/L EDTA (p H 8.0)

Double distilled water WdH20 ) dilution I : 10.

Apparatus

Beckman rotor, SW28 or equivalent

Membrane (0.45 um, 500 ml)

Incubation, 30°C or 37°C

SW 28 Ultra-Clear Beckman Tubes

Tissue Culture Plates (I O c m )

Methods

1 The day before transfection, IOcm plates of DMEM medium were inoculated with 293T cells at 10% confluence. On the day of transfection, cells were 40%~70% confluent.

2. 2 h before transfection, replace the fresh DMEM medium.

3. Mix e n v, pack, t a n s plasmids and plasmids coding for D A F or fusion protein g p 6 4 -D A F or V S V - G - D A F according to the need of the experiment according to the proportions (Table 1, Table 2).

4- Add 125ul 2m o l / L CaClundefined 2○ ul ○ - I X T E to the plasmid mixture and add d d H 20 total volume to l m l .

5- Add I m l of DNA mixture dropwise to I m l of 2 X H B S. Shake at maximum speed and allow to stand for 30 min.

6- Slowly add precipitate dropwise to the cell.

7. Incubate for 16 h.

Generate DAF-modified gp64 or VSV-O pseudotyped HIV-I-derived lentiviral vectors by coexpression of gp64-DAF or VSV-ODA F-fusion proteins, incubating at 30°C instead of the standard 37°C .

8 . Remove the medium and replace with 10 to 12 m l of fresh complete medium. Virus collection, filtration, concentration

9. 48 h after transfection, collect the medium and add fresh 10~12m l medium to the cell plate.

10.0.45um membrane filtration of the collected medium. Store the culture medium at 80°C.

11. Repeat steps 8~9 daily (2~3d after the first collection of VS V-G pseudotyped virus, 4~6d after the collection of gP 64 pseudotyped virus).

Because VSV-G cytotoxicity rarely produces VSV-G pseudotyped plasmid cells that survive beyond 4d, compared to gP64 low-toxicity cells that can survive one week after transfection with gp64 in the collection medium.

12. Confluence the collected medium. Ultra-clear tubes (max. 30 ml/tube) are centrifuged for 2 h at 25,000 rpm at 4°C with a S W 28 rotor.

13. Remove the upper layer of liquid and resuspend the precipitate in complete DME medium. Store the resuspended plasmid at 80°C for further analysis.

In vitro serum inactivation analysis material

reagents

Cells, exponentially growing 293 or H T 1080 (human fibrosarcoma)

DMEM medium (complete and serum-free) containing 10 % fetal bovine serum

Human serum complement (CHM > 100; normal and heat-inactivated)

Inactivate complement, incubate at 56°C for lh.

Polybrene

Pseudotyped H IV-I-derived lentiviral vectors ( >107 transfection units/m l )
Plasmids encoding green fluorescent protein should be constructed.
Instrumentation

Water bath 37°C and 56°C

Oscillating mixer

Methods

1- Dilute 100ul carrier with an equal amount of human normal serum complement. Heat-inactivated human serum or complete D M E M medium was used as a control.

2-Incubate the carrier-complement mixture at 37°C for l h . Vibrate for 2 s every 15 m i n .

3- After incubation, dilute the reaction solution 10-fold with serum-free DMEM.

4 . Infect H T 1080 or 293 cells with serial dilutions of viral vectors containing encoded G FP in the presence of Polybrene at 8 wow/1111.

5. 48 h after transduction, G FP positive counts were performed on culture plates containing the highest dilution of viral vector.

6. Calculate the viral titer (positive expression as G F P transduction units/m l ; G F P -T U /m l ).
Viral titer = ( number of G F P foci X dilution factor)/volume of vector used for transduction


For more product details, please visit Aladdin Scientific website.

https://www.aladdinsci.com/

Categories: Protocols
Explore topics: Other experiments

Da — when not otherwise indicated, molecular weight units are daltons.   Mw — weight-average molecular weight.   Mn — number-average molecular weight.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Cite this article

Aladdin Scientific. "Preparation of pseudotyped lentiviral vectors resistant to complement inactivation" Aladdin Knowledge Base, updated Dec 24, 2024. https://www.aladdinsci.com/us_en/faqs/preparation-of-pseudotyped-lentiviral-ve-en.html
Was this article helpful? Yes No 0 out found this helpful

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.